Exelixis, Inc. (EXEL)
41.82
+0.75
(+1.83%)
USD |
NASDAQ |
Mar 17, 16:00
41.82
0.00 (0.00%)
After-Hours: 19:08
Exelixis Shareholders Equity (Quarterly) : 2.161B for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Natera, Inc. | 1.712B |
| Merck & Co., Inc. | 52.61B |
| Castle Biosciences, Inc. | 470.87M |
| Alnylam Pharmaceuticals, Inc. | 789.18M |
| Bio-Techne Corp. | 2.011B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 2.882B |
| Total Liabilities (Quarterly) | 720.71M |
| Debt to Equity Ratio | 0.093 |
| Current Ratio | 3.558 |
| Net Debt Paydown Yield | -0.01% |